NLRP3 and colitis: APS can also downregulate the expression of NLRP3, caspase-1, and ASC in colon tissue, prevent the activation of the NLRP3 inflammasome, thereby reducing the expression of IL-18 and IL-1β and alleviating DSS-induced colon inflammation (Tian et al., 2017).